BACKGROUND: Readmissions after radical cystectomy are common, burdensome, and poorly understood. For these reasons, the authors conducted a population-based study that focused on the causes of and time to readmission after radical cystectomy. METHODS: Using Surveillance, Epidemiology, and End Results-Medicare data, at total of 1782 patients who underwent radical cystectomy from 2003 through 2009 were identified. A piecewise exponential model was used to examine reasons for readmission as well as patient and clinical factors associated with the timing of readmission. RESULTS: One in 4 patients (25.5%) were readmitted within 30 days of discharge after radical cystectomy. Compared with patients without readmission, those readmitted were similar with regard to age, sex, and race. Readmitted patients had more complications (33.8% vs 13.9%; P< .001) and were more likely to have been discharged to skilled nursing facilities from their index admission (P< .001). The average time to readmission and subsequent length of stay were 11.5 days and 6.7 days, respectively. The majority of readmissions (67.4%) occurred within 2 weeks of discharge, 66.8% had emergency department charges, and 25.9% involved intensive care unit use. Although the spectrum of reasons for readmission varied over the 4 weeks after discharge, the most common included infection (51.4%), failure to thrive (36.3%), and urinary (33.2%) and gastrointestinal (23.1%) etiologies; 95.8% of patients had ≥ 1 of these diagnosis groups present at the time of readmission. CONCLUSIONS: Readmissions after radical cystectomy are common and time-dependent. Interventions to prevent and reduce the readmission burden after cystectomy likely need to focus on the first 2 weeks after discharge, take into consideration the spectrum of reasons for readmission, and target high-risk individuals.
BACKGROUND: Readmissions after radical cystectomy are common, burdensome, and poorly understood. For these reasons, the authors conducted a population-based study that focused on the causes of and time to readmission after radical cystectomy. METHODS: Using Surveillance, Epidemiology, and End Results-Medicare data, at total of 1782 patients who underwent radical cystectomy from 2003 through 2009 were identified. A piecewise exponential model was used to examine reasons for readmission as well as patient and clinical factors associated with the timing of readmission. RESULTS: One in 4 patients (25.5%) were readmitted within 30 days of discharge after radical cystectomy. Compared with patients without readmission, those readmitted were similar with regard to age, sex, and race. Readmitted patients had more complications (33.8% vs 13.9%; P< .001) and were more likely to have been discharged to skilled nursing facilities from their index admission (P< .001). The average time to readmission and subsequent length of stay were 11.5 days and 6.7 days, respectively. The majority of readmissions (67.4%) occurred within 2 weeks of discharge, 66.8% had emergency department charges, and 25.9% involved intensive care unit use. Although the spectrum of reasons for readmission varied over the 4 weeks after discharge, the most common included infection (51.4%), failure to thrive (36.3%), and urinary (33.2%) and gastrointestinal (23.1%) etiologies; 95.8% of patients had ≥ 1 of these diagnosis groups present at the time of readmission. CONCLUSIONS: Readmissions after radical cystectomy are common and time-dependent. Interventions to prevent and reduce the readmission burden after cystectomy likely need to focus on the first 2 weeks after discharge, take into consideration the spectrum of reasons for readmission, and target high-risk individuals.
Authors: Brian J Minnillo; Matthew J Maurice; Nicholas Schiltz; Aiswarya C Pillai; Siran M Koroukian; Firouz Daneshgari; Sim P Kim; Robert Abouassaly Journal: Can Urol Assoc J Date: 2015 Jul-Aug Impact factor: 1.862
Authors: Tudor Borza; Bruce L Jacobs; Jeffrey S Montgomery; Alon Z Weizer; Todd M Morgan; Khaled S Hafez; Cheryl T Lee; Benjamin Y Li; Hye Sung Min; Chang He; Scott M Gilbert; Jonathan E Helm; Mariel S Lavieri; Brent K Hollenbeck; Ted A Skolarus Journal: Urology Date: 2017-03-04 Impact factor: 2.649
Authors: Carmit McMullen; Matthew Nielsen; Alison Firemark; Patricia Merino Price; Denise Nakatani; Jean Tuthill; Ruth McMyn; Anobel Odisho; Michael Meyers; David Shibata; Scott Gilbert Journal: Support Care Cancer Date: 2018-06-06 Impact factor: 3.603
Authors: Bruce L Jacobs; Chang He; Benjamin Y Li; Alex Helfand; Naveen Krishnan; Tudor Borza; Amir A Ghaferi; Brent K Hollenbeck; Jonathan E Helm; Mariel S Lavieri; Ted A Skolarus Journal: J Surg Res Date: 2017-02-23 Impact factor: 2.192
Authors: Peter S Kirk; Ted A Skolarus; Bruce L Jacobs; Yongmei Qin; Benjamin Li; Michael Sessine; Xiang Liu; Kevin Zhu; Scott M Gilbert; Brent K Hollenbeck; Ken Urish; Jonathan Helm; Mariel S Lavieri; Tudor Borza Journal: BJU Int Date: 2019-08-11 Impact factor: 5.588
Authors: Kenneth L Urish; Yongmei Qin; Benjamin Y Li; Tudor Borza; Michael Sessine; Peter Kirk; Brent K Hollenbeck; Jonathan E Helm; Mariel S Lavieri; Ted A Skolarus; Bruce L Jacobs Journal: J Arthroplasty Date: 2018-04-17 Impact factor: 4.757